(MedPage Today) — Note that some links may require registration or subscription.
The FDA reportedly told drugmakers that approved monoclonal antibodies to protect infants against respiratory syncytial virus (RSV) would be subject to new safety…
Source link : https://www.medpagetoday.com/pediatrics/rsv/118903
Author :
Publish date : 2025-12-09 14:32:00
Copyright for syndicated content belongs to the linked Source.
